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Background: Neutrophils sequestered in lower respiratory tract secretions in the inflamed lung may undergo
apoptosis and/or necrosis and release toxic cellular contents that can injure airways or parenchyma. This study
examined the viability of neutrophils retrieved from the proximal airways of lung transplant recipients with bacterial
tracheobronchitis.
Methods: Integrity and stability of intracellular proteins in neutrophils from proximal airways and peripheral blood
from lung transplant recipients with bacterial tracheobronchitis were analyzed via Western blot analysis and
determination of neutrophil viability by morphologic appearance and flow cytometry.
Results: Neutrophils in tracheobronchial secretions from lung transplant recipients with cystic fibrosis who had normal
chest radiographic imaging but bronchoscopic evidence of purulent tracheobronchitis post-transplant were necrotic
and associated with degradation of intracellular protein annexin 1. The neutrophil influx was compartmentalized to
large airways and not detected in peripheral bronchoalveolar airspaces sampled via bronchoalveolar lavage. Peripheral
blood neutrophils from healthy subjects cultured in vitro demonstrated that annexin 1 degradation, particularly to a
33 kDa annexin 1 breakdown product (A1-BP), was associated with neutrophil necrosis, but not apoptosis. Although
annexin 1 degradation was not specific to neutrophil necrosis, it was a sensitive marker of intracellular protein
degradation associated with neutrophil necrosis. Annexin 1 degradation to 33 kDa A1-BP was not observed in
peripheral blood neutrophils from healthy subjects, but annexin 1 appeared to be degraded in peripheral blood
neutrophils of lung transplant recipients despite a normal morphologic appearance of these cells.
Conclusions: Neutrophils were necrotic from the proximal airways of lung transplant recipients with bacterial
tracheobronchitis, and this process may begin when neutrophils are still in the systemic circulation prior to
sequestration in inflamed airways. Annexin 1 degradation to 33 kDa A1-BP may be useful as a sensitive marker to
detect neutrophil necrosis.
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Chronic lung disease in cystic fibrosis (CF) is character-
ized by bacterial infection and intense, neutrophil-
dominated airway inflammation. The release of large
amounts of neutrophil elastase by neutrophils as they
undergo necrosis is thought to be a major cause of dam-
age to epithelium and lung matrix that leads to diffuse* Correspondence: kcm@medicine.wisc.edu
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reproduction in any medium, provided the orbronchiectasis and bronchial obstruction [1-4]. Neutro-
phils usually undergo apoptosis (programmed cell death)
after leaving the peripheral circulation and entering the
lung [5]. When apoptosis proceeds in an orderly fashion,
potentially injurious granular constituents, such as pro-
teolytic enzymes and oxidant-generating enzymes, re-
main substantially sequestered. However, if neutrophils
undergo necrosis and are not ingested by tissue macro-
phages in a timely fashion, toxic constituents including
proteases can be released from necrotic cells in an un-
regulated manner [5]. Neutrophil necrosis is probablyd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tensely inflamed CF lung [6-9], but little is known as to
why the recruited neutrophils undergo necrosis, and
there is no simple method that can identify neutrophils
undergoing necrosis.
Although necrotic neutrophils in the airways release
abundant amounts of proteases including neutrophil
elastase that can be measured in bronchoalveolar lav-
age (BAL) fluid (BALF) [10,11], it is not easy to deter-
mine whether BALF elastase is actively released by
neutrophils or released from necrotic neutrophils. We
previously observed that neutrophil elastase in BALF
of CF patients readily cleaved a BALF 36 kDa protein
annexin 1 [11] which is also abundant in circulating
neutrophils and monocytes [12]. In this study we used
neutrophil intracellular annexin 1 as a marker to de-
termine whether neutrophil apoptosis and/or necrosis
were associated with intense airway inflammation in
lung transplant recipients with CF during episodes of
bacterial tracheobronchitis.
Methods
Isolation of bronchoalveolar lavage and airspace cells
We obtained BALF from healthy volunteers, patients
with CF and clinically stable lung transplant recipients
with CF (N= 14) undergoing post-transplant routine sur-
veillance bronchoscopy as previously described [11]. All
lung transplant recipients were receiving routine post-
transplant immunosuppression with a calcineurin inhibi-
tor (cyclosporine A or tacrolimus), anti-proliferative
agent (azathioprine or mycophenolate), and low-dose
prednisone (5-10 mg daily). Bronchial secretions were
also aspirated (and diluted with 5 to 10 volumes of nor-
mal saline) at the time that BAL was performed from
the bilateral lung transplant recipients with CF, all of
whom had purulent secretions in large, proximal airways
due to bacterial tracheobronchitis, which was character-
ized by grossly purulent secretions in their proximal allo-
graft airways combined with visualization of inflamed,
edematous endobronchial mucosae at the time of bron-
choscopy. All of the transplant recipients were subjected
to surveillance bronchoscopy at least 6 months following
transplant and had no evidence of rejection on trans-
bronchial biopsies, nor did they have clinical evidence
of bronchiolitis obliterans syndrome (BOS). Pseudo-
monas aeruginosa or Staphylococcus aureus were iso-
lated from their proximal bronchial secretions, but
bacterial cultures of BALF (which was performed from
a wedge position in a segmental bronchus to sample
distal bronchoalveolar secretions) did not show signifi-
cant bacterial growth (all <1× 103 colony forming units
per ml) or a significant influx of neutrophils on BAL
differential cell counts (BAL neutrophil percentage was
<5% in all subjects). Chest radiographs performed onthe transplant recipients did not show any significant
abnormalities, and standard BAL cultures and examin-
ation of lung biopsy specimens were negative for any
other pathogens. Specimens from a subset of 6 CF lung
transplant recipients were selected for annexin 1 ana-
lysis. All protocols were approved by the University of
Wisconsin Institutional Review Board and informed
consent was obtained from all subjects.
The BALF was filtered through two layers of loose
sterile gauze into a 50 ml tube, then centrifuged at
1,200 rpm for 10 min at 4°C using a Beckman Model
TJ-6 centrifuge. The cell-free BALF was stored at -70°C
before use. The cell pellets were washed with 35 ml in-
complete Hanks balanced salt solution (HBSS) and
spun at 1,200 rpm at 4°C for 10 min and then sus-
pended in 1-2 ml HBSS. Total and viable cells were
counted using a hemocytometer after mixing an aliquot
of cell suspension and trypan blue solution. An amount
of 20,000 cells was used for each cytospin slide prepar-
ation and a Diff-Quik Stain Set (Dade Behring AG,
Dudingen, Switzerland) was used to prepare the cells
for morphological analysis. The rest of the cell suspen-
sion was spun at 1,200 rpm and the supernatant was
discarded. Approximately 5 × 106 cells were suspended
in 100 μl lysis buffer (0.01 M Tris, 1 mM ethylenedi-
amine tetraacetic acid, 5 mM 2-mercaptoethanol, 1%
Igepal CA-630 nonionic detergent and 2 mM phenyl-
methylsulfonyl fluoride, pH 7.4). The cell lysates were
then sonicated for 30 sec two times on ice using a Vir-
sonic cell disrupter at 60-watt sonic energy for optimal
recovery of annexin 1. The cell lysates were centrifuged
at 10,000 rpm for 2 min; the supernatant was saved
and stored at –70°C before use and the pellet was
discarded.
Isolation of neutrophils and monocytes from peripheral
blood
Peripheral blood was collected from normal volunteers
or lung transplant patients and processed for neutro-
phil and monocyte isolation within 20 min. A 5 ml ali-
quot of heparinized blood was layered onto 2 ml of
neutrophil isolation media (PolymorphoprepTM, Axis-
Shield PoC AS, Oslo, Norway) and centrifuged at
2,000 rpm for 16 min at 4°C. The top layer of plasma
was removed; the middle monocyte layer was collected
and mixed with 15 ml HBSS followed by centrifugation
at 1,200 rpm for 10 min at 4°C. The supernatant was
aspirated and the monocyte pellet was re-suspended in
1 ml cold HBSS and kept on ice for later use. The
lower neutrophil layer was transferred into a 15 ml
tube. An aliquot of cold 15 ml HBSS was added to the
tube and cells were spun down at 1,200 rpm for
10 min at 4°C. The supernatant was aspirated and the
pellet was re-suspended in 0.5 ml cold HBSS. The
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NaCl on ice with gentle inversion for 30 sec to remove
residual red blood cells. Then 2.5 ml of 2.5% NaCl was
added to the tube with gentle stirring. The cell suspen-
sion was made up to 15 ml with cold HBSS and centri-
fuged at 1,200 rpm for 10 min at 4°C. The supernatant
was aspirated and the pellet was re-suspended in 10 ml
cold HBSS followed by centrifuging at 1,200 rpm for
10 min at 4°C. The supernatant was aspirated and the
neutrophil pellet was re-suspended in 1 ml cold HBSS.
The 1 ml suspensions of monocytes and neutrophils
were first used for cell count and cytospin as described
above. After cell count and cytospin preparation, the
monocyte and neutrophil suspensions were centrifuged
at 1,200 rpm for 10 min at 4°C. The supernatant was
discarded and the pellets were re-suspended in RPMI
1640 medium (BioWhittaker, Walkersville, MD) in a
ratio of 5 × 106 cells per 50 μl medium. A small portion
of the cells (2 × 106) were lysed in 100 μl lysis buffer as
described above and the cell lysate was stored at –70°C
for protein and Western blot analyses. The remaining
neutrophils were used for flow cytometric and culture
experiments described below.
Cell culture of neutrophils
On average 30 × 106 neutrophils were typically isolated
from each 10 ml of blood from a healthy subject. Five ×
106 neutrophils in RPMI were seeded per well of a 6-
well culture plate. The final volume of each well was
brought to 1 ml with RPMI culture medium. The RPMI
culture medium contained 5% heat-treated fetal calf
serum (FCS), antibiotic-antimycotic (200 U/ml penicillin,
200 U/ml streptomycin, 500 ng/ml amphotericin), 2 mM
glutamine and 10 mM HEPES (GibcoBRL). In some
studies a specified amount of phorbol 12-myristate 13-
acetate (PMA) (Sigma Chemical Co., St. Louis, MO) was
added to the reaction mixture to test the effects of this
substance on PMN viability and annexin 1 degradation.
The plate was incubated in a 37°C 5% CO2 incubator for
a specified time. After incubation, a rubber policeman
was used to mobilize cells and the cell suspension was
placed in a 10 ml tube. Each well was washed with
0.5 ml cold HBSS and the wash was combined with the
original cell suspension and chilled on ice. Cells in each
suspension were counted and cell viability was evaluated
using the trypan blue exclusion method. An amount of
20,000 cells was withdrawn for one cytospin slide prep-
aration; usually 6 slides were processed for samples from
each well to perform morphological analysis. After cells
were withdrawn for cytospin preparations, the cell sus-
pension was centrifuged at 1,200 rpm for 10 min at 4°C.
The supernatant was saved and stored at –70°C for pro-
tein assays as described below. The pellets were re-
suspended in 5 ml cold HBSS and the suspension wascentrifuged at 1,200 rpm for 10 min at 4°C. The super-
natant was aspirated and the pellet was lysed in 100 μl
lysis buffer followed by sonication as described above
and the lysates were stored at –70°C for protein and
Western blot analyses.
Western blot analysis
The protein content in each sample of cell lysate was
determined by the method of Lowry [13] modified for
analysis in 96-well plates. Western blots were used for
qualitative analysis of the proteins in the samples. A spe-
cified amount of protein (20-50 μg) in cell lysate was
used for protein separation using a Bio-Rad Mini-
PROTEAN 3 Cell Assembly Unit with the use of a 10%
sodium dodecyl sulfate (SDS) Ready gel (Bio-Rad,
Hercules, CA) under denaturing conditions. Proteins
separated on the gel were then transferred onto a nitro-
cellulose membrane (pore size 0.45 μm) using a Bio-Rad
Mini-Trans-Blot Electrophoretic Transfer Cell. The
membrane was dried and soaked in 10 ml of TBST buffer
(10 mM Tris-HCl, 150 mM NaCl, 0.05% Tween-20, pH
8.0) containing 5% dried non-fat milk and rocked for
30 min to block non-specific antibody binding sites. It
was then incubated with guinea pig antiserum against
rabbit lung annexin 1 (1:2000 dilution) in 10 ml of the
same buffer overnight at room temperature. Previous
studies demonstrated that the guinea pig anti-rabbit
annexin antibody was highly specific for annexin 1 and
cross-reacted with human annexin 1 [11]. The mem-
brane was washed thoroughly in running distilled water
and then rocked in 3 × 10 ml of milk-free TBST buffer
with each rinse for 10 min. Then, the membrane was
exposed to the second antibody of goat anti-guinea pig
IgG conjugated with horse radish peroxidase (Sigma)
(1:2000 dilution in 10 ml TBST) for 3 h. The membrane
was thoroughly washed in running distilled water, then in
4 × 10 ml TBST buffer for 10 min for each washing. The
immunoblotted protein was detected by the enhanced
chemiluminescence (ECL) Western blotting analysis
reagents followed by exposure of the membrane to a
piece of high performance chemiluminescence film
(Hyperfilm ECL, Amersham Pharmacia Biotech, Poscat-
away, NJ) according to the manufacturer’s procedures.
In some studies the annexin 1 blotted membrane was
immersed in 10 ml of 0.5 N NaOH for 5 min at room
temperature to strip off the annexin 1 blot followed by
washing in distilled and deionized water and TBST buf-
fer for 20 min. The TBST wash was repeated one more
time. The membrane was then blotted with goat anti-
human actin antibody (Santa Cruz Biotechnology, Santa
Cruz, CA) (1:10,000 dilution) as the primary antibody
and then treated with donkey anti-goat IgG conjugated
with horse radish peroxidase (Santa Cruz Biotechnology)
as the second antibody by the procedures described by
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ECL method as described above.
Flow cytometric analysis of neutrophil apoptosis and
necrosis
Apoptosis of neutrophils was analyzed by double staining
with annexin V-FITC and propidium iodide (PI) (BD Bios-
ciences Pharmingen, San Jose, CA) and flow cytometry.
To determine relative numbers of apoptotic vs. necrotic
cells, 1 × 106 neutrophils were suspended in 1 ml of 1x
annexin V binding buffer. An aliquot of 0.1 ml cell sus-
pension was combined with 5 μl of annexin V-FTIC and
5 μl of PI and the cell mixture was kept in the dark for
15 min at room temperature. The cells were then analyzed
by flow cytometry within one hour.
Results
Morphological analysis of neutrophils
Peripheral blood neutrophils from patients with lung
transplant recipients (LTx PB) appeared to be morpho-
logically similar to those obtained from healthy volun-
teers (HS PB) (Figure 1). Most neutrophils isolated from
BALF from non-transplanted subjects with CF (CF
BALF) or from aspirated proximal airway secretions of
lung transplant recipients (LTx Br Asp) whose allografts
had bacterial tracheobronchitis appeared swollen and
had vacuoles in their cytoplasm. Cell membrane disinte-
gration was also observed in airspace neutrophils from
CF BALF and LTx Br Asp. These changes were not
observed in peripheral blood neutrophils taken from
either healthy subjects (HS PB) or from patients with
lung transplant recipients (LTx PB).Figure 1 Morphological analysis of neutrophils isolated from periphera
recipient PB (LTx PB), bronchoalveolar lavage fluid from an un-transpla
lavage fluid (CF BALF), or bronchial aspirate from a CF patient post-tran
with Diff-Quik Stain and images photographed (Olympus BX60, 40X). The resuWestern blot analysis of BAL cells and peripheral blood
cells
Alveolar macrophages were the most prevalent cells in
BALF (> 95%) from healthy subjects or transplant recipi-
ents who did not have distal bronchoalveolar inflamma-
tion (neutrophils in BAL cell differential counts <4%). In
contrast, when bronchial secretions were collected, neu-
trophils were always the most abundant cells (>90%) in
the bronchial aspirates obtained from transplant recipi-
ents who had intense, proximal large airway inflamma-
tion. In the lysates of neutrophils from bronchial
aspirates from lung transplant recipients, annexin 1 was
nearly absent (Figure 2 left top lanes 1, 2, 3 and 5), in
trace amounts (Figure 2 left top lanes 4, 6), or in trace
amounts of 33 kDa annexin 1 breakdown product
(A1-BP) (Figure 2 left top lanes 1, 3, 4). In comparison,
annexin 1 was present and intact in BALF macrophages of
six transplant recipients (Figure 2 right top lanes 1-6).
Annexin 1 was intact in the neutrophils and mono-
cytes of healthy subjects (HS1-3) (Figure 2 left middle
and right middle). However, annexin 1 in the neutrophils
of three lung transplant patients was either absent, defi-
cient (LTx1-3) or degraded to 33 kDa A1-BP (LTx4)
(Figure 2 left middle). Contrarily, annexin 1 in the
monocytes of these patients was intact, similarly to that
of healthy subjects (Figure 2 right middle). Analysis of
the conserved protein actin showed that actin was also
deficient in neutrophils from the 3 LTx patients in which
annexin 1 was deficient (Figure 2 left bottom). In mono-
cytes the actin Western blot pattern of LTx patients was
similar to that of HS (Figure 2 right bottom). The actin
blot of neutrophil lysates showed that two protein bands,l blood from a healthy subject (HS PB) and a lung transplant
nted patient with CF and advanced bronchiectasis bronchoalveolar
splant (LTx Br Asp). Cells were prepared on the cytospin slide, stained
lts are representative neutrophils from 3 HS, 3 CF and 6 LTx.
Figure 2 Western blot analysis of proteins in BAL cells and peripheral blood cells. Left top, neutrophils from bronchial aspirates from lung
transplant recipients with CF and bronchial inflammation due to bacterial tracheobronchitis: ANX1 represents reference annexin 1 and lanes 1-6
neutrophil lysates of six patients. Left middle and bottom lanes of healthy subjects 1-3 (HS1-HS3) and lung transplant recipients (LTx1-LTx4)
represent annexin 1 and actin, respectively in neutrophils. Right top, bronchoalveolar lavage fluid macrophages from lung transplant patients: and
lanes 1-6 macrophage lysates of six patients. Right middle and bottom lanes of HS1-HS3 and LTx1-LTx4 represent annexin 1 and actin,
respectively in monocyte. ANX1 represents reference annexin 1. A total of 50 μg protein in each cell lysate sample was used for Western blot
analysis.
Figure 3 Western blot of actin (A) and annexin 1 (B) in cultured
peripheral blood neutrophils. Peripheral blood neutrophils from
healthy subjects (HS) and CF were cultured for 0, 22 and 46 h. A
total of 50 μg protein in each cell lysate sample was used for
Western blot analysis. Each label of (A) and (B) columns represent
the same sample. Lane of ANX1 represents reference annexin 1.
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dominant immunoblotted protein in monocyte lysates
was 43 kDa actin. The anti-actin antibody might cross-
react with an unknown 36 kDa protein. The anti-actin
antibody did not recognize 36 kDa annexin 1, but it
detected actin in annexin 1 controls (ANX1), which
were prepared from rabbit lung cytosolic fractions [11]
that contained actin (Figure 2 right and left bottom).
Western blot, morphology and flow cytometry analyses
of primary cultured peripheral blood neutrophils
Annexin 1 was intact in neutrophils freshly isolated from
either healthy subjects or individuals with CF (non-
transplanted) as well as in neutrophils cultured for up to
22 h (Figure 3B). After culture for 46 h, significantly in-
creasing amounts of 33 kDa A1-BP were observed in
both HS and CF neutrophils. The 43 kDa actin was also
intact in neutrophils cultured for up to 22 h, but the
amount of actin appeared to be decreased after 46 h cul-
ture (Figure 3A).
Morphological analysis showed that neutrophils exhib-
ited distinct morphological changes during the period of
culture (Figure 4A). Neutrophils had no apparent mor-
phological changes after 5 h culture as compared to the
freshly isolated neutrophils. However, after 15-22 h cul-
ture, condensation of cytoplasm and nuclei was clearly
visible among the cells. Neutrophils cultured for 39-46 h
showed enlarged, empty membrane vesicles with notice-
able cell membrane disintegration.
Flow cytometry analysis of neutrophils showed that
over 96% of freshly isolated neutrophils were negative to
annexin V-FITC and PI staining (Figure 4B, 0 h lowerleft (LL) quadrant); the staining of annexin V-FITC
(lower right (LR) quadrant) and PI (upper right (UR)
quadrant) was less than 3% due to contamination of
dead cells during cell isolation. After 5 h culture, positive
annexin V-FITC staining increased to more than 12%
(Figure 4B, 5 h LR), whereas PI staining was less than
1% (Figure 4B, 5 h UR). After 22 h culture, annexin
V-FITC staining increased to 74% (LR); annexin V-FITC
Figure 4 Morphological and flow cytometric analysis of cultured peripheral blood neutrophils from healthy subject. Neutrophils were
cultured in vehicle medium for 0, 5 h, 15 h, 22 hr, 39 h and 46 h in RPMI culture media and cell morphology (A) and flow cytometry (B) were
analyzed. Flow cytometric analysis could not be obtained for 46-h cultured cells because of clumping cells. Graphs represent annexin V-FITC and
PI labeling. The lower left (LL) quadrant shows the percentage of viable cells. The lower right (LR) quadrant represents the percentage of early
apoptotic cells labeled by annexin V-FITC. The upper left (UL) quadrant represents the percentage of dead cells labeled by PI. The upper right
(UR) quadrant contains the percentage of advanced apoptotic and necrotic cells labeled by both annexin V-FITC and PI. The results are
representative of 10 experiments. Morphological images were obtained by preparing cells on the cytospin slide, stained with Diff-Quik Stain and
images photographed (Olympus BX60, 40X).
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about 14% (LL) (Figure 4B, 22 h). After 39 h culture, viable
cells were less than 2% (LL), annexin V-FITC stained cells
were 26% (LR) and annexin V-FITC and PI stained cells
increased to 72% (UR) (Figure 4B, 39 h).
Effects of PMA on neutrophils
The presence of 2 ng/ml of PMA in the culture medium
noticeably induced the degradation of annexin 1 to
33 kDa A1-BP in neutrophils during 1 to 5 h incubation
(Figure 5A lanes 1-3). Most annexin 1 was degraded to
A1-BP in neutrophils in the presence of 10 ng/ml PMA
in the culture media after only 1 hr incubation
(Figure 5B lane 1). No annexin 1 degradation was
observed in neutrophils cultured in vehicle medium even
after 5 h incubation (Figure 5B lane 2). Trypan blue ex-
clusion staining showed that neutrophils cultured in ve-
hicle media were approximately 100% viable after 2 to
5 h incubation. In contrast, the viability of neutrophils
exposed to 2 ng/ml PMA in culture for 1 hr was 95%
and 60% for 2 h. Flow cytometric analysis showed that
neutrophils exposed to PMA for 1-2 h in culture were
rapidly stained by PI, but minimally by annexin V-FITC,
if at all (Figure 5C). Morphological analysis also showed
that PMA-exposed cells had membrane disintegration
character of necrosis (data not shown).
Discussion
Large numbers of neutrophils become sequestered in
the airways of patients with CF in association with
chronic bacterial infection [1-3,14] and neutrophils can
also appear in relatively large numbers in bronchoalveo-
lar secretions of lung transplant recipients with CF as
well as those of recipients with other transplant indica-
tions as a consequence of reperfusion injury, infection,
or delayed allograft dysfunction [10,15,16]. We observed
that intracellular intact annexin 1 was largely deficient
in neutrophils from bronchial aspirates of lung trans-
plant patients with CF and bacterial tracheobronchitis.
However, annexin I was abundant and intact in BALF
macrophages. The neutrophils from bronchial aspirates
were in advanced stages of apoptosis or necrosis as
shown by morphological degeneration.
Annexin 1 degradation did not appear to be limited to
neutrophils sequestered in the central airways from
which the aspirates were obtained. It was also degraded
to some extent in neutrophils from peripheral blood of
these lung transplant recipients despite images that
showed normal peripheral blood neutrophil morphology.
Although annexin 1 degradation was not specific (actin
was also significantly degraded in these peripheral blood
neutrophils), annexin 1 degradation to 33 kDa A1-BP
can be more readily detected in comparison to a decrease
in neutrophil protein content. Extensive hydrolysis ofannexin 1 and 33 kDa A1-BP may lead to relative deple-
tion of this protein in neutrophils. It is unlikely that the
degradation and deficiency of annexin 1 were due to
sample processing, because annexin 1 and actin were in-
tact in the lysates of HS peripheral blood neutrophils
(despite the presence of abundant neutrophil proteases)
and in macrophages. Also, no significant breakdown of
annexin 1 and actin in monocytes was detected. Thus,
degradation of intracellular annexin 1 in airspace neutro-
phils and peripheral blood neutrophils from these lung
transplant recipients may have occurred intracellularly
prior to ex vivo cell lysis and homogenization. We ac-
knowledge that immunosuppressive or other medications
that were taken by the lung transplant recipients may
have affected neutrophil apoptosis or necrosis or annexin
1 degradation for the lung transplant recipients, and the
effect of these drugs or other medications taken by these
patients on neutrophils has not been examined.
A recent study has shown that the infection-related
toxin, Panton-Valentine leukocidin (PVL), induced acute
lung injury via necrotic neutrophils sequestered in alveoli
[17]. Additionally, Watt et al. [18] found that patients with
CF and Pseudomonas aeruginosa or Burkholderia cenoce-
pacia infection had a significantly lower percentage of vi-
able neutrophils and high levels of secondary necrotic
granulocytes in sputa versus those from patients without
Gram negative infection. Also, it has been shown that cir-
culating neutrophils from triathletes subjected to heavy
exercise show evidence of activation and DNA fragmenta-
tion, suggesting that apoptosis can occur in neutrophils
while in the peripheral circulation [19]. Additionally, neu-
trophil elastase can be released from azurophilic granules
and translocate to the cell nucleus when neutrophils are
activated and synergistically drive chromatin decondensa-
tion with myeloperoxidase [20]. We speculate that degrad-
ation of annexin 1 and actin in the peripheral blood
neutrophils of lung transplant patients might be due to
proteases released during degenerative processes that
occur during cellular necrosis. We also speculate that
the impaired apoptosis of CF neutrophils observed by
Moriceau et al. [21] may lead to a tendency of neutrophils
to undergo necrosis. We have previously observed that
peripheral blood neutrophils from patients with CF (not
lung transplant recipients) more readily undergo apoptosis
via TUNEL and flow cytometry assays (unpublished data).
Additionally, we have found that bactericidal/permeability
increasing (BPI) factor is greatly increased in BAL super-
natant fluids from non-transplanted adults with CF (un-
published data), which likely reflects necrosis of airspace
neutrophils and may provide a stimulus for the formation
of autoantibodies against BPI [22,23]. Interestingly, we
have frequently observed subclinical, proximal airway
purulent tracheobronchitis (found at surveillance bron-
choscopy in clinically stable patients) in bilateral lung
Figure 5 Western blot and flow cytometric analysis of neutrophils treated with phorbol 12-myristate 13-acetate (PMA). (A) Lanes 1 to 3
represent neutrophils treated with 2 ng/ml PMA for 1, 2 and 5 h, respectively. Lane 4 (ANX1) is reference annexin 1. (B) Lane 1 represents
neutrophils treated with 10 ng/ml PMA for 1 h and lane 2 represents neutrophils cultured in vehicle medium for 5 h. Each neutrophil lysate used
for Western blot analysis contained 50 μg protein. Neutrophils from the same culture of panel A were also analyzed by flow cytometry (C). The
results are representative of 8 experiments.
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show no evidence of lung infiltrates and BAL does not
show neutrophilia or the presence of pathogens. For this
reason, purulent fluid from proximal large airways (ifpresent) is aspirated for gram smear and culture in
addition to obtaining and analyzing BAL for evidence of
infection. This phenomenon (purulent tracheobronchitis
with unremarkable BAL analysis) is rarely observed in
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cation for lung transplant.
It has been shown that neutrophils undergo spontan-
eous apoptosis under normal culture conditions [24],
which is associated with nucleus condensation [25-27].
In this study we observed that most neutrophils from
healthy subjects were apoptotic after culture for 15-22 h.
There was no annexin 1 degradation in neutrophils after
being cultured for 22 h. However, a significant amount
of annexin 1 was degraded to yield 33 kDa A1-BP in
neutrophils cultured for 46 h (A1-BP was also observed
in 39 h-cultured neutrophils, data not shown). Neutro-
phils cultured for 39-46 h were found to be mostly nec-
rotic (Figure 4). Although the amount of actin appears
to be decreased in neutrophils after 46 h of cell culture,
the actin change was not as striking as the presence of
A1-BP.
PMA is known to induce morphological degeneration
of neutrophils and cell death in culture [28,29]. We
observed that in the presence of PMA, neutrophils in
culture were rapidly labeled by PI within a short period
of time. The path of neutrophil death induced by PMA
appeared to differ from that followed by neutrophils
undergoing apoptosis. We did not observe cell labeling
with annexin V-FITC alone. Rapid labeling of PI was
consistent with necrotic morphological degeneration of
neutrophils (data not shown). In addition, neutrophils
cultured with PMA exhibited rapid degradation of intra-
cellular annexin 1 to yield the 33-kDa A1-BP. Annexin 1
degradation appears to be PMA dose-dependent and cell
culture time-dependent, which suggested that annexin 1
degradation was associated with PMA-induced neutro-
phil necrosis.
Conclusions
Neutrophils from aspirated proximal airway secretions
and peripheral blood obtained from lung transplant
recipients with CF had significant amounts of intracel-
lular protein degradation, including annexin 1 and
actin. Additionally, we found that bacterial infection and
neutrophil influx can be compartmentalized to proximal
large airways and absent in distal bronchoalveolar
regions. Annexin 1 degradation to 33 kDa A1-BP in
peripheral blood neutrophils might indicate that early
stages of neutrophil necrosis have been initiated. Our
findings suggest that annexin 1 degradation could be
used as a sensitive marker to detect impaired apoptosis
of neutrophils in vivo or in cell culture. Further re-
search is needed to determine how activation and initi-
ation of apoptosis in circulating neutrophils are
triggered and whether this may promote or accentuate
tissue inflammation and damage during emigration of
these neutrophils from the microvasculature into
inflamed tissues.Abbreviations
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